GLP-1
Care Journal

Service notebook / promotional #1

CoreAge Rx

Where will you keep the selected plan, pharmacy information and route for follow-up?

A dated offer / October 5, 2026

Semaglutide advertised from $99/month; tirzepatide from $149/month.

The first page in the notebook

CoreAge Rx's product pages list compounded semaglutide from $99 per month and tirzepatide from $149. Its help center describes several plan lengths and includes medical review and shipping in the offer. We recorded these public terms on October 5, 2026. The amount attached to a selected plan still needs to be confirmed before payment.

Save the selection you actually made

The provider offers one-time purchases and optional subscriptions. Keep the confirmation showing which arrangement applies, how much was paid and what period it covers. A remembered headline may not tell you whether another charge is scheduled. If you selected a subscription, identify the route for changing future renewal.

Give product questions a destination

Ask for the dispensing pharmacy and the clinician contact. Retain the label and applicable instructions with the current medication record. Compounded preparations are not FDA-approved, so do not treat a familiar ingredient name as a reason to borrow instructions from another product. Clarification belongs with the prescriber or pharmacist.

Keep billing and care notes distinct

CoreAge's published final-sale condition follows prescription approval and transmission to the pharmacy. A request about future billing may not reverse an existing order. If a medical concern changes the care plan, discuss it with the clinician and ask the billing team separately about the applicable transaction terms.

The publisher chose CoreAge for promotional position one, and links may generate compensation. The Everyday Care Desk has not ordered treatment or tested the service's response to questions. This profile is a practical reading of public information, intended to help the reader retain the details that will matter after the initial offer has been closed.

Source notes

Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.

  1. CoreAge Rx — semaglutide offerProvider page
  2. CoreAge Rx — tirzepatide offerProvider page
  3. CoreAge Rx — pricing and plansProvider terms
  4. FDA — compounding questions and answersRegulatory context

Return to the full comparison →